Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Haorui Industrial Development is a Chinese pharmaceutical company specializing in the research, development, and supply of active pharmaceutical ingredients (APIs) and chemical intermediates. The company is particularly recognized for its expertise in steroid hormones and related derivatives, providing essential components for medications in endocrinology and reproductive health. Shenzhen Haorui operates as a key link in the pharmaceutical supply chain, offering high-purity chemical products to global drug manufacturers and research institutions. Their operations include quality-controlled manufacturing processes and a robust distribution network to ensure the delivery of fine chemicals for diverse therapeutic applications. By maintaining high standards of purity and regulatory compliance, the company supports the development of both generic and innovative small molecule therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Haorui Industrial Dev..